AMY THOMAS: Open Payments
NPI 1447838032 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 40 payments from 11 companies in 2025. Trend: 2023 $1,268 · 2024 $1,378 · 2025 $1,266
Food & beverage: $1,266
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $314 |
| Phathom Pharmaceuticals, Inc. | 6 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $144 |
| Lilly USA, LLC | 1 | $119 |
| Novo Nordisk Inc | 1 | $119 |
| Hologic Sales and Service, LLC | 1 | $89 |
| Paratek Pharmaceuticals, Inc. | 1 | $54 |
| Celltrion USA Inc. | 2 | $35 |
| Ardelyx, Inc. | 1 | $21 |
Products named: VOQUEZNA, SKYRIZI, GATTEX, XIFAXAN, MOUNJARO, Wegovy, CREON, APTIMA.
Industry payments across TX — which companies pay providers there.
